Correspondence Activity Detail
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
Probe Score Breakdown
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted
8-K adjustment, capped at 10.0. This is the 365-day
v1 snapshot. Computed:
Nov. 11, 2026.
Latest filing activity:
Apr. 28, 2026.
These dates describe different events.
Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
| Apr. 28, 2026 |
CORRESP |
Neutral/Informational |
Moderate |
Enveric Biosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by April 29, 2… |
Read Filing
EDGAR
|
| Apr. 27, 2026 |
UPLOAD |
Neutral/Informational |
Low |
The SEC has communicated to Enveric Biosciences, Inc. that it will not review their registration statement filed on April 23, 2026. The letter emphasizes that the responsibility f… |
Read Filing
EDGAR
|
| Feb. 17, 2026 |
UPLOAD |
Concern from SEC |
Moderate |
The SEC has communicated to Enveric Biosciences, Inc. that it will not review the company's registration statement filed on February 10, 2026. The letter emphasizes the company's … |
Read Filing
EDGAR
|
| Feb. 17, 2026 |
CORRESP |
Neutral/Informational |
Moderate |
Enveric Biosciences, Inc. has submitted a request for the acceleration of their Registration Statement on Form S-1, seeking to have it declared effective by the SEC on February 17… |
Read Filing
EDGAR
|
| Dec. 29, 2025 |
CORRESP |
Neutral/Informational |
Moderate |
Enveric Biosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by December 30… |
Read Filing
EDGAR
|
| Dec. 23, 2025 |
UPLOAD |
Neutral/Informational |
Low |
The SEC has communicated to Enveric Biosciences, Inc. that it will not review the company's registration statement filed on December 22, 2025. The letter emphasizes the company's … |
Read Filing
EDGAR
|
| Dec. 8, 2025 |
CORRESP |
Neutral/Informational |
Moderate |
Enveric Biosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by December 8,… |
Read Filing
EDGAR
|
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.